...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: aberaterone
2
Jun 24, 2018 01:32PM
3
Jun 24, 2018 04:00PM

That would be a good reason for Zenith to be doing their trial in combo with enzalutamide versus abiraterone. I wonder what the scientists setting up the trial knew when they were designing the trial?

tada

5
Jun 25, 2018 12:12PM
Share
New Message
Please login to post a reply